TENVIE
Live / Allowed — Published for opposition (as of 03 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 25 Nov 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98871967
- Mark type
- Stylized text
- Filed
- 25 Nov 2024
- Published for opposition
- 03 Mar 2026
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and therapeutic agents for treating neurological, metabolic, cardiometabolic, inflammatory, and ophthalmic diseases
Owner
- TENVIE THERAPEUTICS, INC., Brisbane, CA, US
- TENVIE THERAPEUTICS, INC., Brisbane, CA, US
- NICO Therapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 03 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Mar 2026 — PUBLISHED FOR OPPOSITION
- 25 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Feb 2026 — USE AMENDMENT ACCEPTED
- 02 Feb 2026 — AMENDMENT TO USE PROCESSING COMPLETE
- 02 Feb 2026 — USE AMENDMENT FILED
- 02 Feb 2026 — TEAS AMENDMENT OF USE RECEIVED
- 15 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Nov 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Nov 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 12 Nov 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED